| GTO ID | GTC3238 |
| Trial ID | NCT05620342 |
| Disease | Lung Non-Small Cell Carcinoma | Small Cell Carcinoma | Lung Cancer |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GD2 CAR-T cells |
| Generation | 2nd |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer |
| Year | 2022 |
| Country | United States |
| Company sponsor | UNC Lineberger Comprehensive Cancer Center |
| Other ID(s) | LCCC2115-ATL |
| Cohort 1 | |||||||||
|
|||||||||